Can you provide the upcoming earnings date for BIOAFFINITY TECHNOLOGIES INC?
BIOAFFINITY TECHNOLOGIES INC (BIAF) will report earnings on 2026-05-13.
NASDAQ:BIAF • US09076W3079
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOAFFINITY TECHNOLOGIES INC (BIAF).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-04-01 | Maxim Group | Downgrade | Buy -> Hold |
| 2024-07-23 | Maxim Group | Initiate | Buy |
| 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 2.533M | 9.362M 269.67% | 6.162M -34.18% | 7.453M 20.95% | |
| EBITDA YoY % growth | -7.724M -93.09% | -8.348M -8.08% | -10.068M -20.60% | N/A | |
| EBIT YoY % growth | -7.973M -98.83% | -8.954M -12.29% | -10.573M -18.08% | -11.285M -6.74% | |
| Operating Margin | -314.84% | -95.64% | -171.58% | -151.42% | |
| EPS YoY % growth | N/A 56.70% | N/A 2.38% | N/A 41.46% | -8.26 43.75% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | -2.45 49.00% | -2.14 58.00% | -2.14 54.81% |
| Revenue Q2Q % growth | 1.513M -18.38% | 1.735M 36.72% | 1.943M 34.37% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.088M -17.53% | -2.69M -6.92% | -2.765M -20.60% |
All data in USD
BIOAFFINITY TECHNOLOGIES INC (BIAF) will report earnings on 2026-05-13.
The consensus EPS estimate for the next earnings of BIOAFFINITY TECHNOLOGIES INC (BIAF) is -2.45 USD and the consensus revenue estimate is 1.51M USD.